Clolar and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Clolar (clofarabine), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Diphenhydramine Hydrochloride, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Stroke when taking Clolar. It is created by eHealthMe based on reports of 1,091 people who have side effects when taking Clolar from the FDA, and is updated regularly.

What is Clolar?

Clolar has active ingredients of clofarabine. eHealthMe is studying from 1,093 Clolar users. Check the latest studies of Clolar.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,320 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jun, 28, 2026

1,091 people reported to have side effects when taking Clolar.
Among them, 7 people (0.64%) have Stroke.

Among these 7 people:

How long have people been on Clolar when they have Stroke? *

What is the gender of people who have Stroke when taking Clolar? *

female: 60 %
male: 40 %

What is the age of people who have Stroke when taking Clolar? *

What are other drugs people take besides Clolar? *

Tacrolimus: 1 person, 14.29%
Sirolimus: 1 person, 14.29%
Melphalan: 1 person, 14.29%
Diphenhydramine Hydrochloride: 1 person, 14.29%

What are other side effects people have besides Stroke? *

Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 5 people, 71.43%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 57.14%
Agitation (state of anxiety or nervous excitement): 3 people, 42.86%
Insomnia (sleeplessness): 3 people, 42.86%
Leukopenia (less number of white blood cells in blood): 3 people, 42.86%
Cerebral Artery Occlusion (blockage of blood vessel of brain by fat or clot): 2 people, 28.57%
Embolic Cerebral Infarction (brain stroke due to obstruction of an artery): 2 people, 28.57%
Aplasia (defective development or congenital absence of an organ or tissue): 2 people, 28.57%
Neck Mass (mass in neck): 2 people, 28.57%
Mastoid Disorder (disease of mastoid bone of ear): 2 people, 28.57%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 42.86%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 42.86%
Bone Marrow Conditioning Regimen: 1 person, 14.29%
Acute Leukaemia (blood cancer): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Clolar and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clolar:

Clolar (1,093 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Clolar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,320 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clofarabine (the active ingredients of Clolar) and Clolar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.